Related Experiment Video
Updated: Apr 18, 2026

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
Published on: July 8, 2025
[Post-injection syndrome after depot injection of olanzapine]
Erik B Wilms1, Marijke T van der Velden, Fred H van Essen
1Apotheek Haagse Ziekenhuizen, afd. Klinisch-farmaceutisch en Toxicologisch Laboratorium, Den Haag.
Background:
Olanzapine pamoate injection is an anti-psychotic depot to be administered intramuscularly once every 2-4 weeks. A post-injection syndrome may occur shortly after administration, resulting in an acute intoxication with olanzapine.
Case Description:
A 42-year-old patient with a schizophrenic disorder lost consciousness 30 min after administration of olanzapine pamoate. He was admitted to a nearby hospital with tachycardia, hypotension, pin-point pupils and respiratory distress leading to reduced oxygen saturation. He was ventilated during one night and recovered within 2 days.
Conclusion:
A post-injection syndrome may develop after administration of olanzapine pamoate when the entire dose olanzapine is released at once from the muscle. Therefore, the patient should be observed for at least 3 hours after every injection. The risk of a post-injection syndrome and the necessary observation period should to be taken into account when deciding to start treatment with olanzapine pamoate depot.
Related Concept Videos
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Psychosis: Goals of Pharmacotherapy
Drug toxicity: Idiosyncratic Reactions
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Psychosis and Antipsychotic Drugs: Overview
Antipsychotic Drugs: Typical and Atypical Agents

